(abb. ISUP: International Society of Urological Pathology)
Table 2: Clinically significant (Gleason ≥ 7) and non-clinically
significant (Gleason < 7) prostate cancer distributions
accordindg to patient’s PSA, free PSA, PSA density, free / total PSA
ratio and prostate volume